1. Home
  2. CAII vs ALEC Comparison

CAII vs ALEC Comparison

Compare CAII & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAII

Collective Acquisition Corp. II Class A Ordinary Shares

SELL

Current Price

$10.05

Market Cap

339.7M

Sector

Finance

ML Signal

SELL

Logo Alector Inc.

ALEC

Alector Inc.

SELL

Current Price

$2.55

Market Cap

275.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CAII
ALEC
Founded
2026
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.7M
275.8M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
CAII
ALEC
Price
$10.05
$2.55
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $4.42
AVG Volume (30 Days)
53.4K
★ 1.9M
Earning Date
N/A
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.70
Revenue
N/A
★ $21,045,000.00
Revenue This Year
N/A
$900.51
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.68
Revenue Growth
★ N/A
N/A
52 Week Low
$9.90
$1.09
52 Week High
$10.06
$2.84

Technical Indicators

Market Signals
Indicator
CAII
ALEC
Relative Strength Index (RSI) 78.12 63.67
Support Level N/A $1.90
Resistance Level N/A $2.65
Average True Range (ATR) 0.00 0.22
MACD 0.00 0.04
Stochastic Oscillator 83.36 65.24

Price Performance

Historical Comparison
CAII
ALEC

About CAII Collective Acquisition Corp. II Class A Ordinary Shares

Collective Acquisition Corp II is a blank check company.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: